Home MarketXLS
Dashboard MarketXLS
Screener MarketXLS
Options Profit Calculator MarketXLS
Stock Ranks MarketXLS
Spreadsheet Builder MarketXLS
Documentation MarketXLS
Logout MarketXLS
Enanta Pharmaceuticals Inc. logo

Enanta Pharmaceuticals Inc.

Sector: Healthcare   

Industry: Biotechnology

16.53
 
USD
  
0.58
  
(3.64%)
Optionable: Yes  Market Cap: 337 M  90-day average vol: 262,524

Previous close: 15.95  Open: 16.47  Bid: 15.53  Ask: 17.51
52 week range    
8.08   
   41.45
Peers   
ENZN / 
ABBV / 
JNJ / 
VRTX / 
MRK / 
BMY / 
Last updated: Thursday 28th March 2024
57
MarketXLS Rank
60
Value
76
Technical
36
Quality

Get Access to 1 Billion Usable Market data points IN YOUR EXCEL SHEETS WITH EASY TO USE EXCEL FUNCTIONS

Get started today
Search for a stock

🎉 Exciting news! 🎉

You are invited to join our Discord Channel.

Interact, learn, and grow with experts in the markets!

Join our Discord

Metrics

Peers

StockDividendMarket Cap (B)PEPrice ($)

ABBV

0.0401242 B33.1142.53

BMY

0.0332145 B-27.366.19

ENZN

0 B-10.30.3736

JNJ

0.0247450 B22.1171.06

MRK

0.0356207 B28.877.58

NVS

VRTX

63 B26.9243.26
Financials

ENTA Income Statement

Annual
Sep-14Sep-15Sep-16Sep-17Sep-18Sep-19Sep-20Sep-21Sep-22Sep-23
Basic EPS from continuing operations-3.92-5.91-6.38
Basic EPS total1.884.231.140.933.742.37-1.81-3.92-5.91-6.38
Basic weighted shares outstanding18 M18673.019 M19 M19 M20 M20 M20 M20603.020969.0
Cost of sales-250000.0-200000.0-78 M-118 M168 M-164 M
Depreciation3 M4 M3 M3 M2 M
Depreciation unreconciled-352000.0-639000.0-2 M-2 M-3 M-3 M-4 M
DepreciationAndAmortization-352000.0-639000.0-2 M-2 M-3 M3 M4 M3 M3 M2 M
Diluted EPS total1.84.091.130.913.482.21-1.81-3.92-5.91-6.38
Diluted normalized net income/share-3.92-5.91-6.38
Diluted weighted shares outstanding19 M19295.019 M19 M21 M21 M20 M20 M20603.020969.0
GainOnSaleOfPPE3000.031000.0
GainOnSaleOfSecurity-166000.0347000.029000.0-159000.0-59000.0149000.0-27000.0
GeneralAndAdministrativeExpense10 M14 M17 M21 M23 M26 M27 M33 M45 M53 M
Gross operating profit48 M161 M88 M103 M207 M205 M122 M97 M86 M79 M
Income before tax19 M125 M33 M27 M93 M46 M-35 M-108 M-122 M-131 M
Income taxes-15 M46 M11 M9 M21 M-826000.01 M-29 M-433000.03 M
Interest income467000.0968000.02 M2 M5 M9 M6 M2 M2 M11 M
InterestExpenseNonOperating18000.08000.045000.040000.05 M
MiscOtherSpecialCharges236000.0509000.0471000.0660000.09 M-27000.083000.0
Net income from total operations34 M79 M22 M18 M72 M46 M-36 M-79 M-122 M-134 M
NetIncomeCommonStockholders34 M79 M22 M18 M72 M46 M-36 M-79 M-122 M-134 M
NetIncomeContinuousOperations34 M79 M22 M18 M72 M46 M-36 M-79 M-122 M-134 M
NetIncomeDiscontinuousOperations554000.0518000.0
NetNonOperatingInterestIncomeExpense449000.0960000.02 M2 M5 M9 M6 M2 M2 M6 M
Normalized income-103 M
Operating income19 M124 M31 M25 M88 M37 M-42 M-110 M-124 M-137 M
Operating income before depreciation (EBITDA)22 M128 M36 M30 M95 M44 M-31 M-102 M-118 M-126 M
OperatingExpense-29 M37 M57 M78 M118 M168 M164 M207 M210 M216 M
Other income net166000.0-347000.0-29000.0159000.059000.0-9 M-149000.027000.0-83000.0
OtherGandA10 M14 M17 M21 M23 M26 M27 M33 M45 M53 M
OtherOperatingExpenses-324000.0-294000.0-134000.0-563000.0-156000.0-11000.0-10000.0-10000.0-882000.0
ProvisionForGainLossOnDisposal554000.0518000.0
RentAndLandingFees10 M14 M17 M21 M23 M26 M27 M
Research & development expense19 M23 M40 M57 M95 M142 M137 M174 M165 M164 M
ResearchExpense19 M23 M40 M57 M95 M142 M137 M174 M165 M164 M
SalariesAndWages-3 M-6 M-9 M-13 M-16 M-19 M-20 M
Selling Gen & administrative expense10 M14 M17 M21 M23 M26 M27 M33 M45 M53 M
Total Income available for interest expense (EBIT)19 M125 M33 M27 M93 M46 M-35 M-108 M-122 M-126 M
Total common shares outstanding19 M19 M19 M19 M19 M20 M20 M20 M21 M21 M
Total net income34 M79 M22 M18 M72 M46 M-36 M-79 M-122 M-134 M
Total ordinary shares21 M21 M21 M21 M21 M21 M21 M21 M21 M21 M
Total revenues48 M161 M88 M103 M207 M205 M122 M97 M86 M79 M
TotalExpenses-29 M-37 M57 M337 M207 M210 M216 M
TotalRevenue48 M161 M88 M103 M207 M205 M122 M97 M86 M79 M
Call: 1-877-778-8358
Ankur Mohan MarketXLS
Welcome! I'm Ankur, the founder and CEO of MarketXLS. With more than ten years of experience, I have assisted over 2,500 customers in developing personalized investment research strategies and monitoring systems using Excel.

I invite you to book a demo with me or my team to save time, enhance your investment research, and streamline your workflows.
Implement “your own” investment strategies in Excel with thousands of MarketXLS functions and templates.

We respect your privacy and will never share your email.
MarketXLS is a complete Excel stock solution

Kevin Hsu

StockKevin.com

I have used lots of stock and option information services. This is the only one which gives me what I need inside Excel

Lloyd Lenase

Option Day Trader

MarketXLS is a data junkie’s dream. It gives me the flexibility to mine for hidden treasures.

Dave

Swing trader since 2011

I like to access historical closing prices on a particular date. That makes tracking performance easy.

Patrick Cusatis, Ph.D., CFA

Associate Professor of Finance - Penn State University